LKYSF - Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC
Events subsequent to quarter-end include $40.25 million financings and Phase 1 clinical trial
VANCOUVER, BC, April 29, 2021 /CNW/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its second-quarter financial results for the three months ended February 28, 2021.
In the second quarter, Numinus raised significant funds and advanced its compassionate access trial portfolio, acquisition strategy and innovation agenda while creating a strong foundation for long-term, sustainable growth across all lines of business.
All financial results are ...
Get the latest stock market news on StreetSignals . Follow public companies and get free stock research reports and stock market analysis data and stock tips.
All content provided by StreetSignals is subject to our Terms Of Use and Disclaimer .
For further details see:
Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC